Study to Determine the Efficacy of Adalimumab in the Treatment of Cutaneous Sarcoidosis

Stopped Dr. Jorizzo has decided to withdraw from this study due to the time it is taking to get the study started.

Conditions

• Sarcoidosis

Interventions

• DRUG: adalimumab

Sponsor

Wake Forest University